The ups and downs of addiction: Role of metabotropic glutamate receptors

Trends in Pharmacological Sciences

Volumn 25, Issue 5, 2004, Pages 265-272

  Kenny, Paul J ^a   Markou, Athina ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; AMPHETAMINE; BAY 367620; COCAINE; EGLUMETAD; LY 314582; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR AGONIST; METABOTROPIC RECEPTOR ANTAGONIST; NICOTINE; UNCLASSIFIED DRUG;

ADAPTATION; ADDICTION; BEHAVIOR; CONDITIONING; DRUG USE; DRUG WITHDRAWAL; HUMAN; MOTIVATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SELF STIMULATION; SYNAPSE;

BRAIN; HUMANS; RECEPTORS, METABOTROPIC GLUTAMATE; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS;

EID: 2142757234     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2004.03.009     Document Type: Review

References (54)

1. Kim J.H., Vezina P. Metabotropic glutamate receptors are necessary for sensitization by amphetamine. NeuroReport. 9:1998;403-406
2. Arai I., et al. Methamphetamine-induced sensitization of dopamine release via a metabotropic glutamate receptor mediated pathway in rat striatal slices. Jpn. J. Pharmacol. 73:1997;243-246
3. Mao L., Wang J.Q. Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioral sensitization to repeated amphetamine administration. Synapse. 41:2001;230-240
4. Kim J.H., Vezina P. The mGlu2/3 receptor agonist LY379268 blocks the expression of locomotor sensitization by amphetamine. Pharmacol. Biochem. Behav. 73:2002;333-337
5. Dingledine R., et al. The glutamate receptor ion channels. Pharmacol. Rev. 51:1999;7-61
6. Sugiyama H., et al. A new type of glutamate receptor linked to inositol phospholipid metabolism. Nature. 325:1987;531-533
7. Conn P.J., Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37:1997;205-237
8. Schoepp D.D. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J. Pharmacol. Exp. Ther. 299:2001;12-20
9. Xiao B., et al. Homer: a link between neural activity and glutamate receptor function. Curr. Opin. Neurobiol. 10:2000;370-374
10. Gasparini F., et al. Allosteric modulators of group I metabotropic glutamate receptors: novel subtype-selective ligands and therapeutic perspectives. Curr. Opin. Pharmacol. 2:2002;43-49
11. Roche K.W., et al. Homer 1b regulates the trafficking of group I metabotropic glutamate receptors. J. Biol. Chem. 274:1999;25953-25957
12. Rong R., et al. PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis. Nat. Neurosci. 6:2003;1153-1161
13. Brakeman P.R., et al. Homer: a protein that selectively binds metabotropic glutamate receptors. Nature. 386:1997;284-288
14. Cartmell J., Schoepp D.D. Regulation of neurotransmitter release by metabotropic glutamate receptors. J. Neurochem. 75:2000;889-907
15. Olds J., Milner P.M. Positive reinforcement produced by electrical stimulation of the septal area and other regions of rat brain. J. Comp. Physiol. Psychol. 47:1954;419-427
16. Markou A., Koob G.F. Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations. Physiol. Behav. 51:1992;111-119
17. Bespalov A., et al. Excitatory amino acid receptor antagonist kynurenic acid attenuates rewarding potential of morphine. Eur. J. Pharmacol. 264:1994;233-239
18. Harrison A.A., et al. Nicotine potentiation of brain stimulation reward reversed by DHβE and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats. Psychopharmacology (Berl.). 160:2002;56-66
19. Taber M.T., Fibiger H.C. Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: modulation by metabotropic glutamate receptors. J. Neurosci. 15:1995;3896-3904
20. Kenny P.J., et al. Group II metabotropic and α-amino-3-hydroxy-5- methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats. J. Pharmacol. Exp. Ther. 306:2003;1068-1076
21. Kenny P.J., et al. The metabotropic glutamate 5 receptor antagonist MPEP decreased cocaine self-administration but not cocaine-induced facilitation of brain reward function in rats. Behav. Pharmacol. 14:2003;S55
22. De Vry J., et al. Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu(1) receptor antagonist BAY 36-7620. Eur. J. Pharmacol. 428:2001;203-214
23. Caine, B. and Koob, G.F. (1993) Intravenous drug self-administration techniques in animals. In Behavioural Neuroscience: a Practical Approach (Shagal, A., ed.), pp. 117-143, IRL Press.
24. Xi Z.X., Stein E.A. Blockade of ionotropic glutamatergic transmission in the ventral tegmental area reduces heroin reinforcement in rat. Psychopharmacology (Berl.). 164:2002;144-150
25. Chiamulera C., et al. Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat. Neurosci. 4:2001;873-874
26. Paterson N.E., et al. The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice. Psychopharmacology (Berl.). 167:2003;257-264
27. Sharko, A.C., et al. (2002) Involvement of metabotropic glutamate receptor subtype 5 (mGlu5) in alcohol self-administration and sedation. Soc. Neurosci. Abstr. 783.781.
28. Weiss F., Baptista M. mGlu2/3 agonist (LY379268) selectively reverses conditioned reinstatement of cocaine seeking behavior. Behav. Pharmacol. 14:2003;S27
29. Vorel S.R., et al. Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science. 292:2001;1175-1178
30. Sutton M.A., et al. Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour. Nature. 421:2003;70-75
31. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 56:1998;613-672
32. Bespalov A. The expression of both amphetamine-conditioned place preference and pentylenetetrazol-conditioned place aversion is attenuated by the NMDA receptor antagonist (+/-)-CPP. Drug Alcohol Depend. 41:1996;85-88
33. Popik P., Wrobel M. Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist. Neuropharmacology. 43:2002;1210-1217
34. McGeehan A.J., Olive M.F. The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse. Synapse. 47:2003;240-242
35. Markou A., Kenny P.J. Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories. Neurotox. Res. 4:2002;297-313
36. Ahmed S.H., et al. Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nat. Neurosci. 5:2002;625-626
37. Kenny P.J., et al. Low dose cocaine self-administration transiently increases but high dose cocaine persistently decreases brain reward function in rats. Eur. J. Neurosci. 17:2003;191-195
38. Manzoni O.J., Williams J.T. Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal. J. Neurosci. 19:1999;6629-6636
39. Martin G., et al. Chronic morphine treatment selectively augments metabotropic glutamate receptor-induced inhibition of N-methyl-D-aspartate receptor-mediated neurotransmission in nucleus accumbens. J. Pharmacol. Exp. Ther. 288:1999;30-35
40. Xi Z.X., et al. Modulation of group II metabotropic glutamate receptor signaling by chronic cocaine. J. Pharmacol. Exp. Ther. 303:2002;608-615
41. Robbe D., et al. Metabotropic glutamate receptor 2/3-dependent long-term depression in the nucleus accumbens is blocked in morphine withdrawn mice. Eur. J. Neurosci. 16:2002;2231-2235
42. Neugebauer V., et al. Cocaine and kindling alter the sensitivity of group II and III metabotropic glutamate receptors in the central amygdala. J. Neurophysiol. 84:2000;759-770
43. Yu, M.F., et al. (2001) Amphetamine induces differential changes in the gene expression of metabotropic glutamate receptor 5 in cultured cortical and hippocampal neurons. J. Mol. Neurosci. 17, 13-24.
44. Yu, M.F., et al. (2003) Activation of metabotropic glutamate receptor 5 is associated with effect of amphetamine on brain neurons. Synapse 50, 334-344.
45. Ghasemzadeh M.B., et al. Neuroadaptations in ionotropic and metabotropic glutamate receptor mRNA produced by cocaine treatment. J. Neurochem. 72:1999;157-165
46. Swanson C.J., et al. Repeated cocaine administration attenuates group I metabotropic glutamate receptor-mediated glutamate release and behavioral activation: a potential role for Homer. J. Neurosci. 21:2001;9043-9052
47. Helton D.R., et al. LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats. Neuropharmacology. 36:1997;1511-1516
48. Fundytus M.E., Coderre T.J. Effect of activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors on morphine dependence. Br. J. Pharmacol. 113:1994;1215-1220
49. Fundytus M.E., et al. Attenuation of morphine withdrawal symptoms by subtype-selective metabotropic glutamate receptor antagonists. Br. J. Pharmacol. 120:1997;1015-1020
50. Fundytus M.E., Coderre T.J. Attenuation of precipitated morphine withdrawal symptoms by acute i.c.v. administration of a group II mGluR agonist. Br. J. Pharmacol. 121:1997;511-514
51. Vandergriff J., Rasmussen K. The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal. Neuropharmacology. 38:1999;217-222
52. Martin H., et al. The mGlu5 receptor antagonists MPEP and MTEP attenuate morphine withdrawal in rats. Soc. Neurosci. Abstr. 2003;575.577
53. Taylor J.R., et al. A comparison of the effects of clonidine and CNQX infusion into the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat. Psychopharmacology (Berl.). 138:1998;133-142
54. Shaw-Lutchman T.Z., et al. Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal. J. Neurosci. 22:2002;3663-3672